Company Update (NYSE:COV): European Commission Clears Medtronic Acquisition of Covidien

[Thomson Reuters ONE] – MINNEAPOLIS AND DUBLIN, Ireland – Nov. 28, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the European Commission has conditionally cleared Medtronic`s proposed . . . → Read More: Company Update (NYSE:COV): European Commission Clears Medtronic Acquisition of Covidien Similar Articles: Company Update (NYSE:COV): Medtronic Acquisition of Covidien Receives U.S. FTC Clearance Company Update: Covidien plc (NYSE:COV) – Covidien Reports Fourth-Quarter and Fiscal 2014 Results Stock Update (NYSE:COV): Covidien’s HawkOne™ Directional Atherectomy System Receives FDA 510(K) Clearance for the Treatment of Peripheral Arterial Disease